A Pharmacokinetic Study of Udenafil in Adult Subjects With or Without Impaired Hepatic Function
Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
This study is designed to assess the effect of hepatic impairment on the pharmacokinetics,
safety and tolerability of udenafil in subjects with hepatic impairment compared to healthy
subjects.